Legend Biotech Corp (LEGN)
40.94
+1.19
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
40.95
+0.01
(+0.02%)
After-Hours: 20:00
Legend Biotech Total Assets (Quarterly): 1.736B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.736B |
| June 30, 2024 | 1.798B |
| March 31, 2024 | 1.775B |
| December 31, 2023 | 1.849B |
| September 30, 2023 | 1.839B |
| June 30, 2023 | 1.931B |
| March 31, 2023 | 1.209B |
| December 31, 2022 | 1.331B |
| June 30, 2022 | 1.023B |
| Date | Value |
|---|---|
| March 31, 2022 | 1.041B |
| December 31, 2021 | 1.119B |
| September 30, 2021 | 813.76M |
| March 31, 2021 | 615.25M |
| December 31, 2020 | 722.09M |
| September 30, 2020 | 708.64M |
| June 30, 2020 | 772.86M |
| March 31, 2020 | 364.94M |
| December 31, 2019 | 287.72M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
287.72M
Minimum
Dec 2019
1.931B
Maximum
Jun 2023
1.163B
Average
1.080B
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 178.29B |
| Ligand Pharmaceuticals Inc | 954.87M |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 13.59M |
| IGC Pharma Inc | 10.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 619.72M |
| Shareholders Equity (Quarterly) | 1.116B |
| Debt to Equity Ratio | 0.2658 |
| Current Ratio | 4.984 |
| Net Debt Paydown Yield | -0.06% |